Centbutindole vs trifluoperazine: a double-blind controlled clinical study in acute schizophrenia.
J Postgrad Med
;
1989 Jan; 35(1): 3-8
Article
Dans Anglais
| IMSEAR
| ID: sea-117542
ABSTRACT
Twenty-nine acute schizophrenic patients were treated under double-blind conditions for six weeks with either centbutindole in a dose range of 3 mg/day to 4.5 mg/day or trifluoperazine in the dose range of 15 mg/day to 22.5 mg/day. Both drugs produced a significant improvement in initial psychopathology. No significant differences were demonstrated between the two treatment conditions.
Texte intégral:
Disponible
Indice:
IMSEAR (Asie du Sud-Est)
Sujet Principal:
Pyrazines
/
Schizophrénie
/
Trifluopérazine
/
Femelle
/
Humains
/
Mâle
/
Répartition aléatoire
/
Méthode en double aveugle
/
Essais cliniques comme sujet
/
Adulte
Type d'étude:
Essai clinique contrôlé
langue:
Anglais
Texte intégral:
J Postgrad Med
Année:
1989
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS